AC Immune (ACIU) Prepaid Assets (2014 - 2025)
AC Immune (ACIU) reported Prepaid Assets of $5.0 million for Q4 2025, up 1.2% year-over-year from $4.9 million in Q4 2024, and up 20.69% on a QoQ basis from $4.1 million in Q3 2025.
AC Immune (ACIU) has 12 years of Prepaid Assets data on file, last reported at $5.0 million in Q4 2025.
- Quarterly Prepaid Assets rose 1.2% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (up 1.2% YoY) and the FY2025 annual result came in at $4.8 million, down 2.45% from the prior year.
- Prepaid Assets rose to $5.0 million in Q4 2025 per ACIU's latest filing, from $4.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.3 billion in Q4 2023 and bottomed at $3.0 million in Q3 2022.
- The 5-year median for Prepaid Assets is $4.9 million (2024), against an average of $968.6 million.
- The widest annual swing landed in 2023, when Prepaid Assets surged 148391.31%; it then sank 99.93% in 2024.
- Tracing ACIU's Prepaid Assets over 5 years: stood at $3.3 billion in 2021, then tumbled by 99.85% to $4.9 million in 2022, then surged by 148391.31% to $7.3 billion in 2023, then slumped by 99.93% to $4.9 million in 2024, then increased by 1.2% to $5.0 million in 2025.
- Per Business Quant, the three latest ACIU Prepaid Assets figures stand at $5.0 million (Q4 2025), $4.1 million (Q3 2025), and $3.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 4.01 Mn |
| Dec 31, 2024 | 4.91 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | 4.27 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 7.26 Bn |
| Sep 30, 2023 | 6.27 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | 5.88 Mn |
| Dec 31, 2022 | 4.89 Mn |
| Sep 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 3.04 Mn |
| Dec 31, 2021 | 3.27 Bn |
| Sep 30, 2021 | 2.11 Bn |
| Jun 30, 2021 | 2.99 Bn |
| Mar 31, 2021 | 3.68 Bn |
| Dec 31, 2020 | 4.37 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 3.83 Mn |
| Mar 31, 2020 | 3.53 Mn |
| Dec 31, 2019 | 2.83 Mn |
| Sep 30, 2019 | 3.04 Mn |
| Jun 30, 2019 | 2,909.15 |
| Mar 31, 2019 | 3.01 Mn |
| Dec 31, 2018 | 2.38 Mn |
| Dec 31, 2017 | 1.48 Mn |
| Sep 30, 2017 | -733,746.43 |
| Jun 30, 2017 | -696,289.11 |
| Mar 31, 2017 | 2.27 Mn |
| Dec 31, 2016 | 1.28 Mn |
| Sep 30, 2016 | -505,384.46 |
| Jun 30, 2016 | -1.82 Mn |
| Mar 31, 2016 | -687,724.81 |
| Dec 31, 2015 | 2.53 Mn |
| Sep 30, 2015 | -1.23 Mn |
| Dec 31, 2014 | 146,301.10 |